Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy Article

cited authors

  • Stinchcombe, TE; Morris, DE; Moore, DT; Bechtel, JH; Halle, JS; Mears, A; Deschesne, K; Rosenman, JG; Socinski, MA

authors

Publication Date

  • April 1, 2006

webpage

published in

category

keywords

  • chemotherapy
  • combined modality therapy
  • induction chemotherapy
  • non-small cell tung cancer
  • stage III
  • tumor volume

start page

  • 67

end page

  • 74

volume

  • 52

issue

  • 1